Healthcare provider profile · identity verified

Kristin E Devor, D.O.

Family Practice · UPPER ARLINGTON, OH · NPI 1538395066

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	321	95
Lisinopril	Lisinopril	189	52
Levothyroxine Sodium	Levothyroxine Sodium	167	47
Losartan Potassium	Losartan Potassium	125	38
Hydrochlorothiazide	Hydrochlorothiazide	122	36
Rosuvastatin Calcium	Rosuvastatin Calcium	106	29
Amlodipine Besylate	Amlodipine Besylate	102	34
Metoprolol Succinate	Metoprolol Succinate	99	30
Alendronate Sodium	Alendronate Sodium	97	21
Omeprazole	Omeprazole	92	33
Trazodone Hcl	Trazodone Hcl	73	20
Eliquis	Apixaban	61	15
Pantoprazole Sodium	Pantoprazole Sodium	57	17
Bupropion Xl	Bupropion Hcl	56	16
Mounjaro	Tirzepatide	56	suppressed
Gabapentin	Gabapentin	51	16
Simvastatin	Simvastatin	50	13
Metformin Hcl	Metformin Hcl	48	13
Metformin Hcl Er	Metformin Hcl	42	12
Pravastatin Sodium	Pravastatin Sodium	42	11
Fluoxetine Hcl	Fluoxetine Hcl	41	12
Synthroid	Levothyroxine Sodium	40	12
Buspirone Hcl	Buspirone Hcl	39	12
Metoprolol Tartrate	Metoprolol Tartrate	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	21
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Tramadol Hcl	Tramadol Hcl	35	14
Duloxetine Hcl	Duloxetine Hcl	34	11
Escitalopram Oxalate	Escitalopram Oxalate	34	12
Sertraline Hcl	Sertraline Hcl	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Promethazine Hcl	Promethazine Hcl	31	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Prednisone	Prednisone	28	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Furosemide	Furosemide	24	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	24	19
Atenolol	Atenolol	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	20	20
Meloxicam	Meloxicam	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Estradiol	Estradiol	19	suppressed
Ozempic	Semaglutide	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	17	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Spironolactone	Spironolactone	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Junel	Norethindrone Ac/Eth Estradiol	12	suppressed
Np Thyroid	Thyroid,pork	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Ramipril	Ramipril	11	suppressed
Water	Water For Irrigation,sterile	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error